Alison Francis Lawton
Director, Cubist Pharmaceuticals.
Companies
- ProQR Therapeutics N.V.Board member Mar 18, 2026 to now1
- Magenta TherapeuticsBoard member Dec 23, 2020 to now2
- X4 Pharmaceuticals, IncBoard member Oct 6, 2020 to Jun 11, 20243
- Aeglea BioTherapeuticsBoard member Dec 17, 2020 to Jun 30, 20234
- Kaleido Biosciences, Inc.Board member Feb 27, 2019 to Apr 17, 20205
- Kaleido Biosciences, Inc.Officer Feb 27, 2019 to Apr 17, 20205
- Verastem OncologyBoard member Nov 27, 2012 to Jun 25, 20196
- Cubist PharmaceuticalsBoard member Feb 17, 2012 to Jan 21, 20157
- Tempest Therapeutics, Inc.Chief operating officer Feb 1, 2013 to Jun 11, 20138
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- X4 Pharmaceuticals, Inc XFOR96,667 shares9$248.0K at $2.56Jun 10, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 10, 2024Granted 45,000 shares of X4 Pharmaceuticals, Inc9
- Jun 13, 2023Granted 45,000 shares of X4 Pharmaceuticals, Inc10
- Jun 6, 2022Granted 6,667 shares of X4 Pharmaceuticals, Inc11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARMagenta Therapeutics, Board member
- 3
- 4SEC EDGARAeglea BioTherapeutics, Board member
- 5
- 6SEC EDGARVerastem Oncology, Board member
- 7SEC EDGARCubist Pharmaceuticals, Board member
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 14, 2023
- 11SEC EDGARForm 4 filed Jun 27, 2022